nach oben

International Journal of Hematology

Erschienen in:

01.12.2012 | Letter to the Editor

Severe bone marrow failure associated with human parvovirus B19 infection in a case with no underlying disorder

verfasst von: Chihiro Kawakami, Yukako Kono, Akiko Inoue, Kimitaka Takitani, Takayuki Ikemoto, Hiroshi Tamai

Erschienen in: International Journal of Hematology | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Excerpt

Human parvovirus B19 (B19) is known to induce erythema infectiosum. B19 mainly attacks the erythroid progenitor cells of the bone marrow and arrests their proliferation [1], but generally these alterations improve spontaneously within a short period. We report a previously healthy boy with persistent severe bone marrow aplasia associated with B19 infection. …

Anderson MJ, Higgins PG, Davis LR, et al. Experimental parvoviral infection in humans. J Infect Dis. 1985;152:257–65.PubMedCrossRef

Takahashi T, Ozawa K, Takahashi K, et al. Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. Blood. 1990;75:603–10.PubMed

Millia F, Feliy E, Riberal JM, et al. Electron microscopic identification of parvovirus virions in erythroid and granulocytic-line cells in a patient with human parvovirus B19 induced pancytopenia. Leuk Lymphoma. 1993;10:483–7.CrossRef

Kurtzman GJ, Gascon P, Caras M, Cohen B, Young NS. B19 parvovirus replicates in circulating cells acutely infected patients. Blood. 1988;71:1448–54.PubMed

Srivastava A, Bruno E, Breddel R, et al. Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood. 1990;76:1997–2004.PubMed

Hanada T, Koike K, Takeya T, et al. Human parvovirus B19-induced transient pancytopenia in a child with hereditary spherocytosis. Br J Haematol. 1988;70:113–5.PubMedCrossRef

Kurtzman GJ, Cohen B, Meyers P, et al. Persistent B19 parvovius infection as a course of severe chronic anaemia in children with acute lymphocytic leukemia. Lancet. 1988;2:1159–62.PubMedCrossRef

Osaki M, Matsubara K, Iwasaki T, et al. Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease. Ann Hematol. 1999;78:83–6.PubMedCrossRef

Kondo Y, Kakami M, Kawaguchi H, et al. Transient pancytopenia associated with parvovirus infection in a healthy child. Pediatr Int. 2002;44:695–7.PubMedCrossRef

10.

Yetgin S, Cetin M, Ozyurek E, et al. Parvovirus B19 infection associated with severe aplastic anemia in an immunocompetent patient. Pediatr Hematol Oncol. 2004;21:223–6.PubMedCrossRef

11.

Seo JY, Kim HJ, Kim SH. Neutropenia in parvovirus B19-associated pure red cell aplasia. Ann Hematol. 2011;90:975–8.PubMedCrossRef

Titel: Severe bone marrow failure associated with human parvovirus B19 infection in a case with no underlying disorder
verfasst von: Chihiro Kawakami
Yukako Kono
Akiko Inoue
Kimitaka Takitani
Takayuki Ikemoto
Hiroshi Tamai
Publikationsdatum: 01.12.2012
Verlag: Springer Japan
Erschienen in: International Journal of Hematology / Ausgabe 6/2012
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI: https://doi.org/10.1007/s12185-012-1214-7

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Severe bone marrow failure associated with human parvovirus B19 infection in a case with no underlying disorder

Excerpt

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2012

Spontaneous improvement of chronic immune thrombocytopenia in children: experience of 56 patients at a single institute

Hemorrhagic-acquired factor XIII deficiency associated with tocilizumab for treatment of rheumatoid arthritis

A tetraploid minimally differentiated acute myeloblastic leukemia with extensive erythrophagocytosis: a case report and literature review

Influence of warfarin dose-associated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin

Bortezomib regulates the chemotactic characteristics of T cells through downregulation of CXCR3/CXCL9 expression and induction of apoptosis

Dr. E. Donnall Thomas

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie